Clinical Trial

Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through Exercise

Study acronym: THOR-X
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The main objective of this project is to analyze the effect of a tailor-made, one-to-one, exercise program (aiming to treat and handle obesity-related comorbidities in adolescents with severe obesity at high risk of cardiovascular disease development) on BMI z-score, specific comorbidities, and other health-related indicators. This project will further allow to analyze the long-term impact of the exercise program not only on clinical parameters, but also on the interaction with drug-treatment, health-related behaviors, and quality of life, further contributing to the understanding of the individual characteristics associated with a positive exercise response and frequency. The secondary objective of the THOR-X project is to build an educational toolkit, based on project results and relevant literature, addressed to health and exercise professionals, in order to improve management of adolescents with obesity, in particular those with severe obesity.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-22.
Trial Details
NCT Number NCT06520800
Lead Sponsor University of Lisbon
Collaborators: Lusofona University
Conditions Adolescent Obesity, Hypertension,Essential, Non-Alcoholic Fatty Liver Disease, Dyslipidemias, Metabolic Disease, Metabolic Syndrome
Enrollment 24 participants
Start Date 2025-01
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-29